Platform Biotechnologies: Public Domain vs Monopoly
Dr. Richard Jefferson of Cambia shares his experience about non-exclusive patent licensing and how it is crucial for future explorations and innovations in the field of biotechnology.
Get the latest reports & analysis with people's perspective on Protests, movements & deep analytical videos, discussions of the current affairs in your Telegram app. Subscribe to NewsClick's Telegram channel & get Real-Time updates on stories, as they get published on our website.
